A Global Perspective from the Prostate Cancer World Congress
TRUS guided prostate biopsy and our post-procedure complications
BPE and incidental carcinoma of the prostate in Kosovo
ProPSA and the Prostate Health Index in the role of prostate cancer diagnosis. Where are they now? A review of the current literature
Usefulness of cystography after radical retropubic prostatectomy: a prospective comparison between cystography and pericatheter retrograde urethrography
Transperineal limited sector biopsy is as accurate as transperineal template saturation biopsy in prostate cancer detection
Continuous versus interrupted vesico-urethral anastomosis in open retropubic radical prostatectomy: comparison of operative outcomes and complications
Anxiety in men with prostate cancer treated by active surveillance
Short-term outcomes of high-intensity focused ultrasound as a first-line therapy for high-risk prostate cancer
Are more low risk prostate cancers detected by repeated biopsy?
Rehabilitation of patients after treatment for prostate cancer
Data mining is a tool for prognosis of the oncological process
Robotic prostatectomy: anaesthesia, challenges and complications
Superior functional and equivalent oncological outcomes are achieved by converting to robotic prostatectomy, however the learning curve is long
Post-TRUS sepsis: targeted use of prophylactic ertapenem for high-risk patients
Incursion into periprostatic fat is a more important determinant of prostate cancer recurrence than an invasive phenotype
Polyethylene glycol hydrogel spacer use significantly reduces rectal radiation dose in patients undergoing high dose rate prostate brachytherapy
Long term Erectile Function (EF) and factors influencing EF preservation following permanent seed Brachytherapy (BT) for localized prostate cancer
Laparoscopic Radical Prostatectomy in a regional centre – Is it possible to establish a fellowship training program in a single surgeon setting during
Volumetric Modulated Arc Therapy (VMAT) to the pelvic lymph nodes in prostate cancer – the first Australian experience
How well do men report their prostate-specific antigen testing status?
The relationship between solar UV exposure, serum vitamin D levels and prostate specific antigen levels, in men from NSW, Australia
Treatment and survival outcomes for prostate cancer for Aboriginal men in New South Wales (NSW) Australia
The distribution of prostate-specific antigen (PSA) profiles in healthy men aged 40–80 years in a multiethnic population
Practical aspects and learning curve for laparoscopic radical prostatectomy: analysis of 300cases performed by a single surgeon
Denosumab and zoledronic acid (ZA) treatment in patients with genitourinary (GU) cancers and bone metastases
Continence after retropubic radical prostatectomy: achieving outcomes without a robot
The predictive factors for neutropenia induced by docetaxel-based systemic chemotherapy in patients with castration-resistant prostate cancer
Comparison of the results of standard and extended pelvic lymph node dissection in prostate cancer patients: improving of 5-year progression free survival
Functional and oncologic outcomes of graded bladder neck preservation during robot-assisted radical prostatectomy
Long-term safety and efficacy analysis of abiraterone acetate (AA) plus prednisone (P) in study COU-AA-302for metastatic castration-resistant prostate cancer
Survival disparities between Māori and non-Māori men with non-localised prostate cancer in New Zealand
What do men say about diagnostic pathways? From prostate-specific antigen (PSA) test to prostate cancer
Screening for prostate cancer in rural men in New Zealand
Assessment of incontinence and urinary quality of life scores as a metric of long term urinary outcomes following robotic assisted radical prostatectomy
A double blind, placebo controlled randomised trial (RCT) evaluating the effect of a polyphenol rich whole food supplement on PSA progression in men
Radium-223(Ra-223) safety and efficacy in prostate cancer with bone metastases: phase 3 ALSYMPCA study findings stratified by age
Intravesical prostatic protrusion: as a predictor of early urinary continence recovery after laparoscopic radical prostatectomy
Predictive factors for locally advanced prostate cancer in prostate cancer patients with Gleason score 6or lower
A multi-centre analysis of early urinary continence recovery after robotic assisted radical prostatectomy in older men
Contemporary management of prostate cancer at an Australian tertiary referral centre
Functioanal and early oncological results of radical perineal prostatectomy for the management of clinically locally advanced prostate cancer
Efficacy and safety of abiraterone acetate and prednisolone in Korean and Taiwanese patients with mCRPC after chemotherapy failure
Clinicopathologic features and risk stratification of concomitant prostate cancer found in specimens removed by radical cystoprostatectomy: a prospect
Efficacy of early duloxetine therapy in urinary incontinence occurred after radical prostatectomy
Radical prostatectomy pathological features – changes over 20years in a prostate database of 11499 cases with focus on Gleason score and high grade
Impact of a uro-oncology multi-disciplinary meeting on clinical decision making in prostate cancer
Longitudinal, prospective patient-reported outcomes of patients following robotic surgery for localised prostate cancer
Waiting times from diagnosis to surgery and prostate cancer survival
Angiotensin converting enzyme (ACE) inhibitors: impact on men receiving primary radiotherapy (RT) for prostate cancer (PC)
Should prostate specific antigen (PSA) screening in be used in younger men in Australia?
The factors which affect posterior dissection of the prostate during robot assisted laparoscopic radical prostatectomy
Phase II study of neoadjuvant ‘supercastration’ in men with high risk non-metastatic prostate cancer
A systematic review with meta-analysis of transrectal prostate biopsy versus transperineal prostate biopsy for detecting prostate cancer
Comparison of perioperative results and short-term biochemical recurrence survival in RARP within 2 weeks
Comparison of three nomograms on clinically insignificant prostate cancer: a validation study
Salvage radical prostatectomy: comparing outcomes of a single surgeon series in the advent of a robotic approach
A modular training programme reduces total console time during robotic assisted radical prostatectomy
Salvaging prostate cancer after radiation failure
End of life care for prostate cancer
Emergency admissions for prostate cancer in the United Kingdom
The Bristol robotic prostatectomy programme
TRUS biopsy in the superbug era.Prevalence and predictors of ESBL carriage in an Australian tertiary hospital
Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following TURP for benign disease
Transperineal template biopsy of the prostate: a review of the impact at Alfred Health
Multiparametric MRI in prostate cancer: a retrospective comparative analysis of mpMRI with histopathological outcomes following radical prostatectomy
Sepsis and superbugs: should transperineal biopsy be offered to all prospective prostate biopsy patients?
TRUS biopsy sepsis and use of carbapenem antibiotics at a single high volume local institution
Descriptive epidemiology of prostate cancer in Morocco
Nocturnal versus daytime pad free continence following robot assisted radical prostatectomy (RARP) and implications
Robotic radical prostatectomy in the Victorian public sector: initial experience of 200cases at an academic teaching centre
Be prepared for active surveillance. What should the patient and I expect? A review of 2 year radical prostatectomy specimen in a local hospital in Hong Kong
Early return of continence using a novel tool for identification of the perineal branch of pudendal nerve during da vinci® prostatectomy
Variability in nerve location during da vinci® prostatectomy
Potential chemopreventive effects of diosgenin in the TRAMP mouse model of prostate cancer are mediated through the suppression of multiple pro-inflammatory
Acquisition of epithelial-mesenchymal transition/cancer stem cell is associated with activation of PI3K pathway in prostate cancer radioresistance
The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)
Novel thiosemicarbazone iron chelators reverse the metastatic properties of prostate cancer cells via the iron regulated metastasis suppressor NDRG1
Anthocyanin extracted from black soybean induces apoptosis of DU-145cells in vitro and inhibits xenograft growth
The anti-tumor agent, Dp44mT, can ‘Hijack’ lysosomal P-glycoprotein to overcome multi-drug resistance
Differences in self-reported outcomes of open prostatectomy patients and robotic prostatectomy patients in an international web-based survey
Investigating the epithelial to mesenchymal transition in prostate cancer invasion and metastasis
miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data
mCOPA: analysis of heterogeneous features in cancer expression data
Engineering a high-throughput prostate cancer stem cell niche mimic
Genetic and epidemiological factors impacting significant increases in prostate cancer risk and aggressive disease associated with an African ancestry
Application of PSMA-targeting magnetic nanoparticles into MRI of prostate cancer
The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis
High-throughput 3D tissue culture for prostate cancer drug screening
New tests improving the diagnostic accuracy of prostate biopsies
Curcumin targets unique transcriptional programs in prostate epithelial and fibroblast cell lines
Expression of the TGF-b superfamily cytokine MIC-1/GDF15slows tumor growth but increases metastases in prostate cancer prone TRAMP mice
Androgen influence on prostate cancer exosomes production and content
Epithelial estrogen receptor α (ERα) regulates the proliferation of prostate cancer cells
Genome-wide analyses reveal specific functional repetitive DNA that are proximal to prostate cancer risk alleles
PSA testing of asymptomatic men in general practice – a review
Identification of novel androgen and antiandrogen regulated long noncoding RNAs and protein-coding RNAs in prostate cancer
Daxx regulates mitotic progression and prostate cancer predisposition
Focal adhesion kinase: a mediator of docetaxel-resistance in castrate resistant prostate cancer
Lack of a low-dose radiation adaptive response on prostate cancer progression in the TRAMP model
Culturing prostate cells as 3D micro-aggregates for drug testing
Association and functional analysis of Kallikrein genetic variants with prostate cancer
Metformin modulates key insulin-induced survival pathways in prostate cancer cells
CD151, a novel candidate for regulation of prostate cancer cell motility, invasion and angiogenesis
Insulin increases migration and invasion in androgen deprived prostate cancer cells
Simvastatin suppresses insulin induced steroidogenesis and fatty acid synthesis in prostate cancer
Insulin stimulates fatty acid synthesis and metabolism in androgen deprived human prostate cancer cell lines
Evaluation of the fatty acid synthase inhibitor triclosan in prostate cancer cells
Tetraspanin protein turnover rates vary in prostate cancer cell lines
Androgen responsive non-coding RNA regulates the expression of prostate cancer associated CTBP1in LNCaP
Novel LAT3 inhibitor suppresses prostate cancer cell proliferation
Targeting copper transport for improving chemotherapy of prostate and breast cancer
A novel and inhibitable pro-metastatic mechanism in prostate cancer
Prostate cancer protein markers to determine optimum treatment strategy at diagnosis
Kallikrein-related peptidase 4initiates tumour-stroma cross-talk in prostate cancer
YKL40as a therapeutic target for the treatment of metastatic Prostate Cancer
Parthenolide as a selective radiosensitiser in the treatment and prevention of prostate cancer
Targeting epithelial-mesenchymal plasticity for improved treatments of advanced prostate cancer
The expression and function of GHSROS, a long non-coding RNA encoded by the opposite strand of the ghrelin receptor gene, in prostate cancer
Germline HOXB13G84E mutation and prostate cancer risk: a systematic review and meta-analysis
Single v/s multiple fraction radiotherapy for palliation of painful vertebral bone metastases in prostate cancer: a prospective study
Australian prostate cancer BioResource, 2013
Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells
Loss of sprouty genes induce prostatic intraepithelial neoplasia
The cross-talk between androgens and cell cycle regulators in prostate tumorigenesis
Post-transcriptional regulation of CD151& CD9 by miRNAs in prostate cancer
Development of a bioengineered model to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer
Protein expression alterations in a unique gleason prostate cancer progression cohort
Use of the CellSearch® platform in enumeration and profiling of circulating tumour cells
Development of automated, multiplexed protein and gene profiling assay for circulating tumor cells (CTCs) of metastatic
Tetraspanins as potential biomarkers in prostate cancer
A Novel exosome based test for prostate cancer
Nuclear localization of the receptor tyrosine kinase EphB4in prostate cancer cells
Role of GADD45G in transcriptional regulation of androgen-responsive genes and prostate cancer cell survival
Do proteases regulate EphB4In prostate cancer?
Analysis of ERG and its metastatic potential in prostate cancer
Hyperglycaemia induced-resistance of prostate cancer cells to docetaxel chemotherapy is mediated via IGFBP-2
The origin of lymph node metastases in prostate cancer
β-catenin signalling in prostate cancer
Functional validation of a KLK3variant, rs17632542, with prostate cancer risk
Targeting Eph receptors and their ephrin ligands in prostate cancer
Isolation and characterization of prostate cancer initiating cells based on aldehyde dehydrogenase activity
Couple distress after localised prostate cancer
An investigation of factors that affect adoption and compliance with post-prostatectomy treatments for erectile dysfunction
Validation of the distress thermometer against three self-report instruments in Australian men with prostate carcinoma
Physical activity, health & wellbeing among men with localised prostate cancer in Queensland: baseline data from the living with prostate cancer study
Localised prostate cancer and the information needs of men to assist in deciding on a treatment option
New prostate cancer diagnoses – Improving timeliness of communication with patients general practitioners
How does psychological resilience “buffer” against depression in prostate cancer patients following diagnosis?
Do hormone treatments cause anxiety and depression among prostate cancer patients?
Prioritising care for newly diagnosed men with prostate cancer: Development of a supportive care needs risk factor assessment tool
Physical activity barriers and facilitators in men with prostate cancer: Influence of androgen deprivation therapy
A cross-sectional comparison of quality of life between physically active and under-active men with prostate cancer
Relationships between perioperative physical activity and post-prostatectomy urinary incontinence: An observational study
Which test to use? A comparison of self-report and objective measures of urinary incontinence after radical prostatectomy
A multicomponent theory-based intervention improves uptake of pelvic floor muscle training before radical prostatectomy: A before and after cohort study
Factors associated with the use of complementary and lifestyle therapies in long term prostate cancer survivors: NSW prostate cancer care and outcomes
A review of the impacts of prostate cancer on the mental health of patients' partners
The experiences of gay and bisexual men diagnosed with prostate cancer: Results from an online focus group
The psychosocial impact of prostate cancer on couples
Depression, anxiety and stress in men with prostate cancer: Is all well?
An evaluation framework for a wider adoption of self-managed interventions during management of advanced prostate cancer
Understanding “Survivorship” in prostate cancer: An investigation of predictors for “Loss of Masculinity” among RADAR participants
Exercise programming requirements for men with prostate cancer
The effects of exercise on treatment side effects for prostate cancer patients receiving androgen deprivation therapy: A systematic review
Safety and efficacy of exercise by prostate cancer survivors with bone metastases
Including the voices of men to improve outcomes in prostate cancer: a national approach
Can exercise prevent treatment toxicity in prostate cancer patients initiating androgen suppression therapy: a randomised controlled trial
Facing the fallout of prostate cancer treatment – a case study
‘Getting Started’ with PRIAS – patience, reliability, invention, action, success – the Geelong urology experience
The evolution of the prostate cancer specialist nurse role in Tamworth, NSW
Are commonly used patient-reported outcome assessment instruments for the assessment of quality of life in surgically treated patients really valid?
Australian men with low risk prostate cancer and their partners' experience of treatment decision-making and active surveillance
Musculoskeletal health in prostate cancer patients treated with androgen deprivation therapy: A review of current practice guidelines